Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human APP/Protease Nexin II (Research Grade Solanezumab Biosimilar) Alexa Fluor 350-conjugated Antibody, R&D Systems™
Human Monoclonal Antibody
Supplier: R&D Systems FAB9919U100UG
This item is not returnable.
View return policy
Description
APP Monoclonal specifically detects APP in Human samples. It is validated for Flow Cytometry.Specifications
APP | |
Monoclonal | |
Alexa Fluor 350 | |
Supplied 0.2Mg/mL in a saline solution containing BSA and Sodium Azide. | |
Human | |
Protein A or G purified from cell culture supernatant | |
Primary | |
Detects Human APP/Protease Nexin II based on Solanezumab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Solanezumab. This product is for research use only. | |
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 degreesC as supplied. | |
IgG1 |
Flow Cytometry | |
Hu13 | |
Flow Cytometry 0.25-1μg/106 cells | |
Amyloid beta, amyloid beta (A4) precursor protein-binding, family B, member 2, amyloid beta A4 precursor protein-binding family B member 2, Amyloid beta precursor protein, APP, beta Amyloid, Protease Nexin II | |
Human APP/Protease Nexin II | |
100 μg | |
351 | |
Human | |
Supernatant |
Provide Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction